1743 related articles for article (PubMed ID: 19374835)
21. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.
Fukushima K; Miyamoto S; Tsukimori K; Kobayashi H; Seki H; Takeda S; Kensuke E; Ohtani K; Shibuya M; Nakano H
Biol Reprod; 2005 Jul; 73(1):172-9. PubMed ID: 15788755
[TBL] [Abstract][Full Text] [Related]
22. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
23. Modulation of expression of LDH isoenzymes in endothelial cells by laminin: implications for angiogenesis.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Biochem; 2008 Apr; 103(6):1808-25. PubMed ID: 18092337
[TBL] [Abstract][Full Text] [Related]
24. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
Delaney CE; Weagant BT; Addison CL
Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
27. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG
J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781
[TBL] [Abstract][Full Text] [Related]
28. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
29. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation.
Abdel-Malak NA; Mofarrahi M; Mayaki D; Khachigian LM; Hussain SN
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):209-16. PubMed ID: 19112164
[TBL] [Abstract][Full Text] [Related]
30. Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways.
Zhao J; Zhao L; Chen W; He L; Li X
Biomed Pharmacother; 2008; 62(6):383-9. PubMed ID: 17826025
[TBL] [Abstract][Full Text] [Related]
31. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha.
Lin CM; Chiu JH; Wu IH; Wang BW; Pan CM; Chen YH
J Nutr Biochem; 2010 Jul; 21(7):627-33. PubMed ID: 19443196
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
34. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways.
Huh JE; Nam DW; Baek YH; Kang JW; Park DS; Choi DY; Lee JD
Int Immunopharmacol; 2011 Jan; 11(1):46-54. PubMed ID: 20959155
[TBL] [Abstract][Full Text] [Related]
35. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
36. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
38. Saikosaponin C induces endothelial cells growth, migration and capillary tube formation.
Shyu KG; Tsai SC; Wang BW; Liu YC; Lee CC
Life Sci; 2004 Dec; 76(7):813-26. PubMed ID: 15581913
[TBL] [Abstract][Full Text] [Related]
39. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production.
Akita S; Daian T; Ishihara H; Fujii T; Akino K
J Dermatol Sci; 2004 Oct; 36(1):11-23. PubMed ID: 15488701
[TBL] [Abstract][Full Text] [Related]
40. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
